JATT II Acquisition Corp Closes $60M IPO on Nasdaq

JATT II Acquisition Corp has closed its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per share. Total gross proceeds were $60,000,000 before underwriting discounts, commissions, and other offering expenses.

The shares began trading on the Nasdaq Global Market under the ticker symbol “JATT” on April 17, 2026. The underwriters received a 45-day option to purchase up to 900,000 additional ordinary shares at the IPO price to cover over-allotments, if any.

JATT II is a newly incorporated blank check company formed to pursue a merger or other business combination, with a stated focus on healthcare and healthcare-related businesses, emphasizing biotechnology and broader life sciences.